↓ Skip to main content

Dove Medical Press

Antileishmanial and antitrypanosomal activity of symmetrical dibenzyl-substituted α,β-unsaturated carbonyl-based compounds

Overview of attention for article published in Drug Design, Development and Therapy, April 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
24 Mendeley
Title
Antileishmanial and antitrypanosomal activity of symmetrical dibenzyl-substituted α,β-unsaturated carbonyl-based compounds
Published in
Drug Design, Development and Therapy, April 2019
DOI 10.2147/dddt.s204733
Pubmed ID
Authors

Abdulsalam AM Alkhaldi, Harry P de Koning, Syed Nasir Abbas Bukhari

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 21%
Student > Master 3 13%
Student > Bachelor 2 8%
Researcher 2 8%
Professor 1 4%
Other 3 13%
Unknown 8 33%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Chemistry 2 8%
Medicine and Dentistry 2 8%
Biochemistry, Genetics and Molecular Biology 2 8%
Mathematics 1 4%
Other 6 25%
Unknown 9 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2022.
All research outputs
#8,266,724
of 25,385,509 outputs
Outputs from Drug Design, Development and Therapy
#580
of 2,268 outputs
Outputs of similar age
#145,030
of 364,372 outputs
Outputs of similar age from Drug Design, Development and Therapy
#10
of 37 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,372 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.